"Baptist Health offers an extensive range of medical, surgical and technological services — including weight-loss surgery, pediatrics, addiction treatment and cancer care — provided by renowned physicians."

During the past decade, Miami Cancer Institute conducted 176 clinical trials. In the 10-year time frame, 176 clinical trials started and 53 clinical trials were completed, i.e. on average, 30.1% percent of trials that started reached the finish line to date. In the past 5 years, 103 clinical trials started and 33 clinical trials were completed. i.e. 32% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Miami Cancer Institute" #1 sponsor was "Children's Oncology Group" with 50 trials, followed by "Memorial Sloan Kettering Cancer Center" with 24 trials sponsored, "National Cancer Institute (NCI)" with 23 trials sponsored, "Baptist Health South Florida" with 21 trials sponsored and "Radiation Therapy Oncology Group" with 21 trials sponsored. Other sponsors include 118 different institutions and companies that sponsored additional 82 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Miami Cancer Institute" #1 collaborator was "National Cancer Institute (NCI)" with 84 trials as a collaborator, "NRG Oncology" with 17 trials as a collaborator, "Merck Sharp & Dohme LLC" with 6 trials as a collaborator, "Bristol-Myers Squibb" with 5 trials as a collaborator and "Cancer and Leukemia Group B" with 5 trials as a collaborator. Other collaborators include 91 different institutions and companies that were collaborators in the rest 75 trials.

According to Clinical.Site data, the most researched conditions in "Miami Cancer Institute" are "Breast Cancer" (10 trials), "Leukemia" (9 trials), "Lung Cancer" (9 trials), "Acute Lymphoblastic Leukemia" (8 trials) and "Glioblastoma" (7 trials). Many other conditions were trialed in "Miami Cancer Institute" in a lesser frequency.

Most popular intervention types in "Miami Cancer Institute" are "Drug" (182 trials), "Radiation" (76 trials), "Other" (66 trials), "Biological" (47 trials) and "Procedure" (41 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (32 trials), "Questionnaire Administration" (21 trials), "Radiation Therapy" (21 trials), "Cyclophosphamide" (19 trials) and "Quality-of-Life Assessment" (18 trials). Other intervention names were less common.

The vast majority of trials in "Miami Cancer Institute" are 229 trials for "All" genders, 19 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are 170 active trials in "Miami Cancer Institute". 2 are not yet recruiting, 92 are recruiting, 75 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 67 completed trials in Miami Cancer Institute, 5 suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Miami Cancer Institute, 31 "Phase 1" clinical trials were conducted, 107 "Phase 2" clinical trials and 92 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 17 trials that are defined as “Not Applicable".